CClinicalTrials.gg
Status unknownNCT03631524IsoRehab2018Updated Nov 9, 2018

Using Telerehabilitation Tools to Deliver Quality Therapy to Patients Under Infective Isolation Precautions

An interventional study of Telerehabilitation in Deconditioning, Isolation Precautions, sponsored by Singapore General Hospital. Status unknown. Open to participants aged 21 Years to 99 Years. Per ClinicalTrials.gov, last updated 2018-11-09.

Sponsored by Singapore General Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
21 Years to 99 Years
Sex
All
01

Study summary

Single blinded Randomised Controlled trial comparing standard therapy to the intervention of up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period. Total recruitment: 60 patients.

Read the detailed description

This is a single blinded randomised control trial. From August 2018 to March 2019, a total of 60 subjects, who match the inclusion exclusion criteria, will be recruited from patients transferred to the SGH Isolation wards.

They will be randomly assigned to control or treatment arm based on a block randomisation strategy predetermined and held by an independent party.

The treatment arm will be given up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period. They will be evaluated for motor strength, activity of daily living performance, mood and perceived level of health.

The control arm will be subject to the same assessments as the treatment arm at the start and end of the two week period. They will receive standard care in the ward including physiotherapy as prescribed by the managing team.

The assessors will be blinded to the arm of the study the subjects will be assigned to and will be independent of the terating physiotherapist.

1.1. Hypothesis We propose that for patients with deconditioning after a prolonged period of hospitalization and needing inpatient isolation precautions, that a 2-week course of daily, up to 1-hour long, physiotherapist-developed resistive training exercises will result in a 20% improvement in the motor power and a corresponding improvement in motor functioning and the perceived quality of life compared to a control group receiving standard therapy.

02

Conditions studied

  • Deconditioning, Isolation Precautions

Keywords

  • deconditioning, isolation precautions, telerehabilitation
03

In context

Lead sponsor

Singapore General Hospital is the lead sponsor of 266 studies on the registry; 57 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    • Able to give consent

      • Admitted to hospital for at least 5 days
      • MMT power grading 2-4/5
      • Isolated for prevention of transmission of MDROs

Exclusion criteria

Exclusion Criteria:

    • Unable or unwilling to consent for the trial

      • Assessed by managing team to be fit for discharge within the next 2 weeks
      • Pregnant women
      • Underlying medical disorders that result in pre-existing lower limb weakness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Conventional therapy

    The control arm will be subject to the same assessments as the treatment arm at the start and end of the two week period. They will receive standard care in the ward including physiotherapy as prescribed by the managing team

  • Experimental
    Intervention arm

    The treatment arm will be given up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period. They will be evaluated for motor strength, activity of daily living performance, mood and perceived level of health.

    Device: Telerehabilitation

Interventions

  • DeviceTelerehabilitation

    The treatment arm will be given up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period.

06

What researchers measure

Primary outcomes

  1. Manual motor power testing

    To assess change in the motor function level (as determined by 1. Medical Research Council (MRC) Manual Muscle Testing (MMT)) at the end of 2 weeks of assessment. 2. To assess change of quadriceps strength using a handheld dynamometer at the end of 2 weeks of assessment

    Time frame: 2 weeks

Secondary outcomes

  1. Volume of therapy

    The number of repetitions of each exercise will be used as corraborative evidence of progress during therapy.

    Time frame: 2 weeks

  2. Functional Independence Measure

    The FIM Provides a uniform system of measurement for disability based on the International Classification of Impairment, Disabilities and Handicaps; measures the level of a patient's disability and indicates how much assistance is required for the individual to carry out activities of daily living based on their score in 18 categories (13 motor and 5 cognitive function items). Each category or item is rated on a 7-point scale (1 = total assistance required, 7 = fully independent). Coster, W. J., Haley, S. M., et al. (2006). "Measuring patient-reported outcomes after discharge from inpatient rehabilitation settings." J Rehabil Med 38(4): 237-242.

    Time frame: 2 weeks

  3. Level of anxiety/ depression

    Hospital Anxiety and Depression Score. The HADS is a fourteen item clinical assessment scale to assess levels of anxiety and depression. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression. The HADS uses an ordinal scale. A number of researchers have explored HADS data to establish the cut-off points for diagnosis of anxiety or depression. A systematic review of a large number of studies identified a cut-off point of 8/21 for anxiety or depression. For anxiety (HADS-A) this gave a specificity of 0.78 and a sensitivity of 0.9. For depression (HADS-D) this gave a specificity of 0.79 and a sensitivity of 0.83.

    Time frame: 2 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with Contact Precautions: a review of the literature. Am J Infect Control. 2009 Mar;37(2):85-93. doi: 10.1016/j.ajic.2008.04.257. PubMed 19249637 ↗
  • Ploutz-Snyder LL, Downs M, Ryder J, Hackney K, Scott J, Buxton R, Goetchius E, Crowell B. Integrated resistance and aerobic exercise protects fitness during bed rest. Med Sci Sports Exerc. 2014 Feb;46(2):358-68. doi: 10.1249/MSS.0b013e3182a62f85. PubMed 24441215 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03631524
Lead sponsor
Singapore General Hospital
Collaborators
National Medical Research Council (NMRC), Singapore
Responsible party
Geoffrey Sithamparapillai Samuel (Consultant, Department of Rehabilitation Medicine, Singapore General Hospital) — Principal investigator
First posted
Aug 15, 2018
Start date
Nov 15, 2018 (estimated)
Primary completion
Dec 20, 2019 (estimated)
Completion
Dec 20, 2019 (estimated)
Last update
Nov 9, 2018

Study contacts

Geoffrey S Samuel, MBBS
Contact
geoffrey.sithamparapillai.samuel@singhealth.com.sg
+6597607935
Geoffrey S Samuel, MBBS
principal investigator · Singhealth Pte Ltd

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion